Literature DB >> 6811179

Associations between systemic lupus erythematosus and the major histocompatibility complex: clinical and immunological considerations.

P H Schur, I Meyer, M Garovoy, C B Carpenter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6811179     DOI： 10.1016/0090-1229(82)90237-9

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN： 0090-1229


× No keyword cloud information.
  13 in total

1.  Antibodies to T- and L-isoforms of the cytoskeletal protein, fimbrin, in patients with systemic lupus erythematosus.

Authors:  E C De Mendonca Neto; A Kumar; N A Shadick; A M Michon; P Matsudaira; R B Eaton; P Kumar; P H Schur
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

2.  Organ specific and multisystemic autoimmune disease: part of a spectrum which may coexist in the same patient.

Authors:  T Gordon; D Isenberg
Journal:  Clin Rheumatol       Date:  1990-09       Impact factor: 2.980

3.  The genetic basis of Ro and La antibody formation in systemic lupus erythematosus. Results of a multicenter study. The SLE Study Group.

Authors:  K Hartung; H Ehrfeld; H J Lakomek; R Coldewey; B Lang; F Krapf; R Müller; D Schendel; H Deicher; H P Seelig
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

4.  Immunogenetic markers in rheumatic diseases.

Authors:  L Martin; M J Fritzler
Journal:  Can Fam Physician       Date:  1990-03       Impact factor: 3.275

5.  Autoimmune sera reactive with Sm antigen contain high levels of RNP-like antibodies.

Authors:  W H Reeves; D E Fisher; R G Lahita; H G Kunkel
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

6.  Evidence against HLA and immunological dependence of disease outbreak in SLE. Immunological characterisation of identical twins clinically discordant for SLE.

Authors:  E Soppi; J Eskola; A Lehtonen
Journal:  Ann Rheum Dis       Date:  1985-01       Impact factor: 19.103

7.  Association of class I, II, and III MHC gene products with systemic lupus erythematosus. Results of a Central European multicenter study.

Authors:  K Hartung; A Fontana; M Klar; H Krippner; K Jörgens; B Lang; H H Peter; W J Pichler; D Schendel; M Robin-Winn
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

8.  Genome scan of human systemic lupus erythematosus by regression modeling: evidence of linkage and epistasis at 4p16-15.2.

Authors:  C Gray-McGuire; K L Moser; P M Gaffney; J Kelly; H Yu; J M Olson; C M Jedrey; K B Jacobs; R P Kimberly; B R Neas; S S Rich; T W Behrens; J B Harley
Journal:  Am J Hum Genet       Date:  2000-11-09       Impact factor: 11.025

9.  Immunoglobulin allotypes are not associated with HLA-antigens, autoantibodies and clinical symptoms in systemic lupus erythematosus. Members of the SLE Study Group.

Authors:  K Hartung; R Coldewey; E Röther; K Pirner; C Specker; D Schendel; W Stangel; S Stannat-Kiessling; G G de Lange
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

10.  Association between a T cell receptor restriction fragment length polymorphism and systemic lupus erythematosus.

Authors:  J G Tebib; J Alcocer-Varela; D Alarcon-Segovia; P H Schur
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.